Pharmacogenomics Focus DNA STAT specializes in pharmacogenomic testing and personalized medicine, presenting a targeted opportunity to cross-sell to clinicians seeking tailored patient care and precision therapeutics.

SME Partner Network With a small team and emphasis on physician and patient support, there is potential to upsell service add-ons, concierge educational support, and training programs to expand practice adoption.

Clinical Utility Expansion Offering testing for nine major enzymes suggests room to broaden panels or integrate results with electronic health records and decision-support tools in partner clinics and hospital systems.

Mid-Market Target Revenue in the low tens of millions with modest employee size indicates DNA STAT may benefit from channel partnerships, white-labeling, or regional hospital networks seeking scalable pharmacogenomics solutions.

Customer Experience Unsurpassed customer service and physician-focused support create a compelling value proposition for sales outreach emphasizing implementation ease, ongoing support, and patient engagement benefits.